Aethlon Medical (NASDAQ:AEMD) Given Buy Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Aethlon Medical (NASDAQ:AEMDFree Report) in a report released on Thursday,Benzinga reports. They currently have a $7.00 target price on the medical equipment provider’s stock.

Separately, StockNews.com started coverage on Aethlon Medical in a report on Monday, January 27th. They set a “sell” rating for the company.

View Our Latest Report on AEMD

Aethlon Medical Trading Down 4.5 %

NASDAQ AEMD opened at $0.70 on Thursday. Aethlon Medical has a 1-year low of $0.24 and a 1-year high of $1.88. The firm’s fifty day simple moving average is $0.58 and its 200-day simple moving average is $0.46. The company has a market capitalization of $9.77 million, a PE ratio of -0.25 and a beta of 1.61.

About Aethlon Medical

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

Further Reading

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.